Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$752K Buy
3,631
+858
+31% +$249K 0.26% 79
2025
Q2
$774K Buy
2,773
+36
+1% +$10.2K 0.23% 94
2025
Q1
$853K Buy
2,737
+11
+0.4% +$3.25K 0.27% 79
2024
Q4
$711K Buy
2,726
+450
+20% +$134K 0.23% 96
2024
Q3
$733K Sell
2,276
-16
-0.7% -$5.23K 0.26% 86
2024
Q2
$716K Sell
2,292
-32
-1% -$9.4K 0.27% 81
2024
Q1
$669K Hold
2,324
0.27% 83
2023
Q4
$669K Sell
2,324
-2,535
-52% -$691K 0.27% 82
2023
Q3
$1.31M Buy
4,859
+1,211
+33% +$302K 0.43% 43
2023
Q2
$755K Sell
3,648
-1,234
-25% -$286K 0.25% 78
2023
Q1
$1.18M Buy
4,882
+1,757
+56% +$431K 0.37% 45
2022
Q4
$647K Sell
3,125
-1,561
-33% -$418K 0.34% 44
2022
Q3
$1.06M Buy
4,686
+1,561
+50% +$378K 0.53% 16
2022
Q2
$643K Sell
3,125
-92
-3% -$22.5K 0.34% 44
2022
Q1
$775K Sell
3,217
-15
-0.5% -$3.45K 0.4% 34
2021
Q4
$723K Buy
3,232
+107
+3% +$22.6K 0.35% 41
2021
Q3
$665K Buy
+3,125
New +$719K 0.36% 44
2020
Q2
Sell
-111
Closed -$23K 49
2020
Q1
$23K Buy
+111
New +$24.2K 0.13% 87

Other funds holding AMGN

Lion Street Advisors's AMGN Position: Q3 2025 in Review

Lion Street Advisors increased its Amgen (AMGN) stake by 31% in Q3 2025, buying an estimated $249K and bringing the position to 3,631 shares worth $752K. The position accounts for 0.26% of the portfolio, ranked #79.

Lion Street Advisors first reported a position in AMGN in Q1 2020 and has held it in 18 quarters since. The position peaked at $1.31M in Q3 2023. 2,826 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Lion Street Advisors held 3,631 shares of Amgen worth $752K as of Q3 2025.
  • Lion Street Advisors bought 858 Amgen shares in Q3 2025, an estimated $249K.
  • Amgen made up 0.26% of Lion Street Advisors's portfolio in Q3 2025, its #79 holding.
  • Lion Street Advisors first reported a position in Amgen in Q1 2020 and has held it in 18 quarters since.
  • Lion Street Advisors's Amgen position peaked at $1.31M in Q3 2023.
  • 2,826 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Lion Street Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.